FEBS Open Bio, EarlyView.CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee +3 more
wiley +1 more source
Blood Donor RBC Genotyping at the National Advisory Unit on Immunohematology at Oslo University Hospital. [PDF]
BiomedicinesAlm IM +5 more
europepmc +1 more source
Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors. [PDF]
, 1997 Marcel Novaes +3 more
openalex +1 more source
HSP70 governs permeability and mechanotransduction in primary human endothelial cells
FEBS Open Bio, EarlyView.HSP70 chemical inhibition reduces endothelial cell proliferation and increases permeability, the latter supported by normal interendothelial junctional protein distribution. HSP70 also plays a role in shear stress response, a hemodynamic force naturally present in blood vessels and correlated with vessel protection.
Andrea Pinto‐Martinez +5 more
wiley +1 more source
Spillovers of Prosocial Motivation: Evidence from an Intervention Study on Blood Donors
, 2014 Adrian Bruhin +3 more
openalex +2 more sources
Intra‐operative acute isovolemic hemodilution is safe and effective in eliminating allogeneic blood transfusions during right hepatic lobectomy: Comparison of living donor versus non‐donors [PDF]
, 2005 Chun H. Rhim +8 more
openalex +1 more source
BLOODR: blood donor and requester mobile application.
mHealth, 2017 Vamsi Krishna Tatikonda, H. El‐Ocla
semanticscholar +1 more source
Thrombolytic proteins profiling: High‐throughput activity, selectivity, and resistance assays
FEBS Open Bio, EarlyView.We present optimized biochemical protocols for evaluating thrombolytic proteins, enabling rapid and robust screening of enzymatic activity, inhibition resistance, and fibrin affinity, stimulation, and selectivity. The outcome translates to key clinical indicators such as biological half‐life and bleeding risk. These assays streamline the development of
Martin Toul +3 more
wiley +1 more source
The "Grey Zone" in Blood Donor Screening: A Retrospective Study and Proposal for Donor Re-Entry. [PDF]
Diagnostics (Basel)Tounsi WA +11 more
europepmc +1 more source
Blood Donor Sex and Outcomes in Transfused Infants. [PDF]
Clin Perinatol, 2023 Salem A, Patel RM.
europepmc +1 more source